Citation

Huckvale R, Harnden AC, Cheung KJ, Pierrat OA, Talbot R, Box GM, Henley AT, de Haven Brandon AK, Hallsworth AE, Bright MD, Akpinar HA, Miller DSJ, Tarantino D, Gowan S, Hayes A, Gunnell EA, Brennan A, Davis OA, Johnson LD, de Klerk S, McAndrew C, Le Bihan YV, Meniconi M, Burke R, Kirkin V, van Montfort RLM, Raynaud FI, Rossanese OW, Bellenie BR, Hoelder S.: Improved Binding Affinity and Pharmacokinetics Enable Sustained Degradation of BCL6 <i>In Vivo</i>. J Med Chem, Volume 65 (12), 2022

Authors

Akpinar HA, Bellenie BR, Box GM, Brennan A, Bright MD, Burke R, Cheung KJ, Davis OA, de Haven Brandon AK, de Klerk S, Gowan S, Gunnell EA, Hallsworth AE, Harnden AC, Hayes A, Henley AT, Hoelder S., Huckvale R, Johnson LD, Kirkin V, Le Bihan YV, McAndrew C, Meniconi M, Miller DSJ, Pierrat OA, Raynaud FI, Rossanese OW, Talbot R, Tarantino D, van Montfort RLM

Journal

J Med Chem

Year

2022

DOI

10.1021/acs.jmedchem.1c02175

PubMed

35653645

Machine-readable

REST APIRDF